CEO Medtech cardiac implants - interventional cardiology

SPAC'HEART; Paris; Sur place; EUR 100 000 - 150 000; Plein temps

Résumé du poste

A medtech startup is seeking a CEO to lead the transformation of a patented hospital research project into a market-ready implantable medical device. The ideal candidate should have over 10 years of experience in the medtech sector, particularly with implantable devices, and a strong ability to secure funding. Key responsibilities include defining the company vision, handling fundraising strategies, and overseeing product development and regulatory compliance. This strategic role is crucial in progressing from prototyping to clinical validation in addressing significant medical needs.

Qualifications

• Minimum of 10 years of experience in the medtech industry, ideally with implantable medical devices.
• Deep understanding of ISO 13485 and regulatory pathways (CE marking, FDA).
• Experience in startup creation or scaling medtech ventures.

Responsabilités

• Define company vision and roadmap.
• Develop fundraising strategy and engage investors.
• Oversee product development and regulatory compliance.

Connaissances

Leadership

Fundraising

Regulatory Strategy

Product Development

Team Building

Description du poste

The CEO will be responsible for transforming a patented hospital-based research project into a robust medtech startup capable of bringing an implantable medical device (class III) to market.

Key responsibilities include :

Leadership & Strategy

• Define the company vision and the regulatory, technical, and commercial roadmap.
• Structure the organization (governance, legal setup, financing, partnerships).
• Build a strong company culture focused on quality, innovation, and clinical impact.

Fundraising

• Develop and execute the fundraising strategy (dilutive and non-dilutive).
• Engage with deeptech / medtech investors, public funding bodies, and specialized funds.
• Manage budgets and supervise external resources.

Product Development & Regulatory

• Oversee prototype development and the overall R&D roadmap.
• Contribute to the regulatory strategy (CE marking, FDA) with specialized consultants.
• Initiate early-stage quality documentation (ISO 13485).
• Coordinate progress on preclinical testing (in-vitro and in-vivo).

Partnerships & Ecosystem

• Collaborate closely with clinicians at the University Hospital of Bordeaux.
• Build a strong network of experts : engineers, CROs, manufacturers, KOLs, consultants, and industry partners.
• Represent the project within the medtech ecosystem and to relevant institutions.

We are seeking a CEO capable of embodying the company’s vision and leading a high-impact clinical and technological project. The ideal candidate will bring strong leadership, strategic insight, and a proven track record in the medtech sector.

Skills and Experience Required

• Minimum of 10 years of proven, successful experience in the medtech industry , ideally involving implantable or cardiac transcatheter medical devices.
• Deep understanding of the medical device development lifecycle (ISO 13485, CE marking, FDA pathways, preclinical and clinical development).
• Demonstrated experience in startup creation, early-stage leadership, or scaling deeptech / medtech ventures.
• Strong ability to secure both dilutive and non-dilutive funding.
• Excellent leadership, communication, and team-building skills, with the capacity to align clinicians, engineers, researchers, and industrial partners around a shared vision.

Additional Assets

• Experience in interventional cardiology, interventional radiology, or transcatheter technologies.
• Expertise in cardiac implants such as valves, stents, or delivery systems.
• Prior involvement in complex regulatory strategies (Class IIb / III devices).

The company is developing a breakthrough innovation in structural cardiology : an intra-cardiac implant delivered via a transcatheter approach, designed to address left ventricular outflow tract obstruction—a complex and insufficiently treated condition.

The startup emerged from research conducted at the University Hospital of Bordeaux, with the participation the local TTO (+500K€ invest).

The project is grounded in strong clinical expertise and a bold technological vision, aiming to transform a clinically identified need into a concrete therapeutic solution.

The company is entering a strategic development phase, progressing from prototyping to early preclinical validation, with the goal of creating a safe, reliable device that addresses a major unmet clinical need.